Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
As of: Oct 21, 2026 · 11:49 AM EDT

Brainstorm Cell Therapeutics (BCLI) Other Accumulated Expenses (2024)

Updated

Brainstorm Cell Therapeutics (BCLI) recorded Other Accumulated Expenses of $300,000 in Q4 2024.

Analysis

Brainstorm Cell Therapeutics (BCLI) Other Accumulated Expenses (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,164.71 Bn 1,133.30 Bn 19.71 Bn
2 Johnson & Johnson 633.37 Bn 551.90 Bn 17.26 Bn
3 AbbVie 503.99 Bn 477.10 Bn 12.70 Bn
4 Merck 378.19 Bn 332.57 Bn 12.21 Bn
5 Novartis Ag 303.15 Bn 267.14 Bn 11.24 Bn
6 Astrazeneca 266.17 Bn 239.85 Bn 12.86 Bn
7 Amgen 241.38 Bn 196.78 Bn 7.24 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn
10 Brainstorm Cell Therapeutics 8.72 Mn 8.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 300,000.00
API Access

Brainstorm Cell Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BCLI&period=max&api_key=YOUR_API_KEY